Graphs and charts displaying clinical trial results for cancer treatment with Nivolumab and ipilimumab, comparing outcomes with and without CMB588. Includes progression-free survival curves, survival rates, response rates, and treatment duration timelines. Data illustrates differences in treatment efficacy.